Dupuytren Contracture
Conditions
Keywords
Ultrasound-Guided Procedure, Dupuytrene's Contracture, Tubiana Grade, Fibrotic Cords Acupotomy, Functional Hand Recovery, Palmar Fascia Fibrosis
Brief summary
This study aims to evaluate the efficacy and safety of ultrasound-guided needle knife dissection in treating Dupuytren's contracture. The procedure is designed to improve hund function and minimize complications associated with the conventional surgical methods.
Detailed description
Dupuytren's contracture is a disease mainly characterized by the progressive fibrosis of the palmar fascia with subsequent hand deformity and dysfunction. The current study seeks to explore, through this minimally invasive technique, ultrasound-guided needle knife dissection regarding ROM and patient satisfaction. The procedure will be carried out under ultrasound guidance to ensure safety and completeness with the accuracy of precise dissection. Primary outcome measures will concern hand mobility, and secondary measures will evaluate patient self-reported satisfaction and any complications for the 6-month follow-up period.
Interventions
This procedure involves a minimally invasive dissection of the fibrous cords in Dupuytren's Contracture using a needle knife guided by ultrasound imaging. Local anesthesia using 3-5 ml of 1% Lidocaine and 0.25% bupivacaine is administered for patient comfort. The technique aims to improve precision, minimize complications and reduce recurrence. Device: Sonosite M-Turbo Ultrasound Machine with Linear Probe HFL38x (6-13 MHz) is used for real-time imaging during the procedure.
Sponsors
Study design
Intervention model description
All participants will undergo ultrasound-guided needle knife dissection for Dupuytren's Contracture treatment.
Eligibility
Inclusion criteria
* Participants diagnosed with Dupuytren's Contracture. * Willing to undergo ultrasound-guided needle knife dissection
Exclusion criteria
* Patients who have undergone previous surgery or needle apponeurotomy for Dupuytren's Contracture on the same hand. * Active hand infections, open wounds, or dermatological conditions in the treatment area. * Coagulopathy or use of anticoagulant that cannot be safely paused * Neuromuscular disorders affecting hand function * Pregnancy or breastfeeding * Uncontrolled systemic illnesses, such as poorly managed diabetes or cardiovascular disease. * Known hypersensitivity to local anesthetics.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in hand Function | 6 months | Functional Improvement: \- Evaluated using the QuickDASH score (0-100 scale). |
| Improvement in hand mobility | 6 months | Range of Motion (ROM): \- Measurment of joint mobility in degrees at MCP and PIP joints by goniometer. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient Satisfaction | 6 months | Evaluation of patient-reported satisfaction using a standardized questionnaire. |
| Rate of procedure-related complications | 6 months | Monitoring and documentation of procedure-related complications, including infection, nerve injury, and other adverse events. |
Countries
Egypt